Cargando…
Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap?
Autores principales: | Smit, M. D., Van Gelder, I. C. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3087023/ https://www.ncbi.nlm.nih.gov/pubmed/21487742 http://dx.doi.org/10.1007/s12471-011-0119-z |
Ejemplares similares
-
Feasibility of TEE-guided stroke risk assessment in atrial fibrillation—background, aims, design and baseline data of the TIARA pilot study
por: Dinh, T., et al.
Publicado: (2011) -
“TEE or not to TEE?”
por: Kapoor, Mukul
Publicado: (2016) -
Study on the correlation between false‐positive filling defect in LAA CT and LAA structure in patients with atrial fibrillation based on TEE
por: Guo, Tian‐Jiao, et al.
Publicado: (2022) -
Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF)
por: Jung, Moonki, et al.
Publicado: (2023) -
Aspirin Use and Risk of Atrial Fibrillation in the Physicians' Health Study
por: Ofman, Peter, et al.
Publicado: (2014)